#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14064	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2248	623.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1771	1771	T	762	T,C	704,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14064	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2248	623.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1505	1505	C	805	C	768	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3704	699.9	0	.	n	.	0	C543T	SNP	543	543	C	992	992	T	829	T	788	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3704	699.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1786	1786	A	895	A	844	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3704	699.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2420	2420	C	815	C	765	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3704	699.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2494	2494	A	782	A	741	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25980	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3704	699.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3046	3046	C	825	C	784	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1940	folP	855	855	99.88	folP.l6.c4.ctg.1	1622	119.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1087	1089	AGC	204;206;207	A;G;C	193;196;195	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4580	gyrA	2751	2751	99.78	gyrA.l6.c30.ctg.1	3291	138.5	0	.	p	.	0	V45I	NONSYN	133	135	GTT	394	396	ATT	148;148;147	A;T;T	131;134;136	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4580	gyrA	2751	2751	99.78	gyrA.l6.c30.ctg.1	3291	138.5	0	.	p	.	0	V290I	NONSYN	868	870	GTT	1129	1131	ATT	162;159;160	A;T;T	152;153;150	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4580	gyrA	2751	2751	99.78	gyrA.l6.c30.ctg.1	3291	138.5	1	SNP	p	S91F	0	.	.	271	273	TCC	532	534	TCC	173;172;170	T;C;C	162;161;161	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4580	gyrA	2751	2751	99.78	gyrA.l6.c30.ctg.1	3291	138.5	1	SNP	p	D95N	0	.	.	283	285	GAC	544	546	GAC	161;162;165	G;A;C	156;156;158	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4580	gyrA	2751	2751	99.78	gyrA.l6.c30.ctg.1	3291	138.5	1	SNP	p	D95G	0	.	.	283	285	GAC	544	546	GAC	161;162;165	G;A;C	156;156;158	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	1650	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1366	120.3	1	SNP	p	G45D	0	.	.	133	135	GGC	483	485	GGC	205;202;203	G;G,T;C	192;188,1;188	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	888	mtrR_promoter	250	250	99.21	mtrR_promoter.l15.c30.ctg.1	1107	80.0	0	.	n	.	0	.206TT	INS	206	206	T	687	687	T	188	T	178	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4582	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2948	154.8	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1487	1489	ATC	200;200;202	A;T;C	183;185;188	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4582	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2948	154.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1640	1642	GCA	188;190;189	G;C,A;A	172;169,1;167	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4582	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2948	154.8	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	195;190;191	G;A;C	176;170;176	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4582	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2948	154.8	1	SNP	p	S87R	0	.	.	259	261	AGT	596	598	AGT	193;192;190	A;G;T	178;177;174	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4582	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2948	154.8	1	SNP	p	S87I	0	.	.	259	261	AGT	596	598	AGT	193;192;190	A;G;T	178;177;174	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4582	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2948	154.8	1	SNP	p	S87W	0	.	.	259	261	AGT	596	598	AGT	193;192;190	A;G;T	178;177;174	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4582	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2948	154.8	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	190;191;194	T,A;C;C	171,1;176;178	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4070	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2629	154.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1511	1513	GGC	212;210;210	G;G;C	202;200;199	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1248	1250	GCA	185;185;187	G;C;A	168;170;173	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1251	1253	ATC	191;192;194	A;T;C	176;176;177	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1263	1265	GTG	196;197;200	G;T;G	182;182;183	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1263	1265	GTG	196;197;200	G;T;G	182;182;183	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1767	1769	ACC	193;191;193	A;C;C	181;178;183	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1821	1823	GCG	194;192;192	G;C;G	181;161;170	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1821	1823	GCG	194;192;192	G;C;G	181;161;170	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1944	1946	GGT	176;175;177	G;G;T	166;161;163	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1953	1955	GGC	173;170;168	G;G;C	159;155;156	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3858	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2454	156.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1971	1973	CCG	146;147;149	C,G;C;G	103,3;112;106	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5524	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3131	176.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1657	1659	CTG	183;184;184	C;T;G	166;164;167	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2014	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1787	112.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	143	C	133	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	D41K	NONSYN	121	123	GAC	385	387	AAA	218;218;218	A,G;A;A,C	203,1;203;202,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	K46S	NONSYN	136	138	AAA	400	402	AGC	205;203;200	A;G;C	194;193;190	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	487	489	ATT	193;193;193	A,G;T;T	179,1;184;183	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	529	531	AGC	209;211;213	A;G,C;C	200;199,1;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	655	657	TAT	223;223;222	T;A;T	208;206;205	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	664	666	GAG	215;216;217	G;A;G	200;202;201	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	V135F	NONSYN	403	405	GTG	667	669	TTT	216;216;214	T;T;T	199;203;201	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	682	684	AAA	218;218;220	A;A;A	206;205;209	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	691	693	CAA	222;222;219	C;A;A	212;210;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	823	825	CGA	250;248;248	C,A;G;A,T	235,1;233;232,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	S189N	NONSYN	565	567	AGC	829	831	AAC	247;246;246	A;A;C	230;225;229	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	H213Y	NONSYN	637	639	CAT	901	903	TAT	201;205;203	T;A;T	195;199;198	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	V215F	NONSYN	643	645	GTT	907	909	TTT	205;202;200	T;T;T	196;194;193	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	F222L	NONSYN	664	666	TTT	928	930	TTG	217;215;216	T,C;T;G	209,1;211;210	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1033	1035	ACG	246;245;247	A;C;G	230;232;234	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2848	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1452	194.6	1	SNP	p	G120K	0	.	.	358	360	GGC	622	624	GGC	201;202;205	G;G;C	192;192;195	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11230	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4727	236.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1901	1903	CAT	251;251;250	C;A;T	236;237;236	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1234	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1113	110.6	1	SNP	p	V57M	0	.	.	169	171	GTG	526	528	GTG	271;270;269	G;T;G	252;251;249	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
